Anti-GD1b Monoclonal Antibody1vial

4-Fluoro-2-methoxypyridine, 95.0%, 10g

5-Bromo-2-methoxy-4-methylpyridin-3-amine, 98%, 1g

3,4,8-trimethyl-7-(1-methyl-2-oxopropoxy)-2H-chromen-2-one, 95.0%, 5g

4-(4-Bromophenyl)-1,2,3-thiadiazole, 97%, 5g

H-Lys(Z)-OBzl.HCl, 95%, 5g

N-(2-hydroxypropyl)acrylamide, 98%, 250mg

(1R,2R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclopentanecarboxylic acid, 95.0%, 250mg

Ethyl 3-oxo-3-(tetrahydrofuran-2-yl)propanoate, 95.0%, 1g

(S)-2-Amino-2-(3-(methylthio)phenyl)ethanol hydrochloride, 97.0%, 100mg

6-Phenylnicotinaldehyde, 95.0%, 1g

tert-Butyl (4-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)cyclohexyl)carbamate, 1g

ROTIPHORESE®50x TAE Buffer, 5 l, plastic, 1 x 5 l